IOVANCE BIOTHERAPEUTICS, INC. Acquisitions, Net of Cash Acquired
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Acquisitions, Net of Cash Acquired of $52.57 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2024-08-08
- IOVANCE BIOTHERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was -$253.00K.
- IOVANCE BIOTHERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $3.38M.
- IOVANCE BIOTHERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $212.63M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-06-30 | $52.57M 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | -$253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.12M derived: sum of 2 quarters · filed 2024-02-28 | $212.63M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $212.89M 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $209.51M 10-Q · filed 2024-08-08 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |